Wed, April 24, 2019
Tue, April 23, 2019
Mon, April 22, 2019
Thu, April 18, 2019
Wed, April 17, 2019
Tue, April 16, 2019
Mon, April 15, 2019
Fri, April 12, 2019
Thu, April 11, 2019
Wed, April 10, 2019
Tue, April 9, 2019
Mon, April 8, 2019
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019
Mon, April 1, 2019
Fri, March 29, 2019
Thu, March 28, 2019
Wed, March 27, 2019
Tue, March 26, 2019
Mon, March 25, 2019
Fri, March 22, 2019

John Newman Maintained (ALRN) at Strong Buy with Decreased Target to $100 on, Apr 9th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-100-on-apr-9th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


John Newman of Canaccord Genuity, Maintained "Aileron Therapeutics, Inc." (ALRN) at Strong Buy with Decreased Target from $380 to $100 on, Apr 9th, 2019.

John has made no other calls on ALRN in the last 4 months.



There is 1 other peer that has a rating on ALRN. Out of the 1 peers that are also analyzing ALRN, 0 agree with John's Rating of Hold.



This is the rating of the analyst that currently disagrees with John


  • Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $140 on, Monday, March 11th, 2019

Publication Contributing Sources